NASDAQ:BOLD - Audentes Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$38.50 0.00 (0.00 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$38.50
Today's Range$37.76 - $39.1155
52-Week Range$17.95 - $46.18
Volume499,588 shs
Average Volume525,491 shs
Market Capitalization$1.64 billion
P/E Ratio-11.32
Dividend YieldN/A

Analyst Ratings

Audentes Therapeutics (NASDAQ:BOLD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Audentes Therapeutics in the last 12 months. Their average twelve-month price target is $33.99, suggesting that the stock has a possible downside of 11.71%. The high price target for BOLD is $49.00 and the low price target for BOLD is $20.00. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.552.452.252.42
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $33.99$32.2122$33.2122$35.4545
Price Target Upside: 11.71% downside30.41% upside42.30% upside4.41% downside

Audentes Therapeutics (NASDAQ:BOLD) Consensus Price Target History

Price Target History for Audentes Therapeutics (NASDAQ:BOLD)

Audentes Therapeutics (NASDAQ:BOLD) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/18/2019HC WainwrightReiterated RatingBuy$33.00 ➝ $44.00LowView Rating Details
2/27/2019William BlairReiterated RatingHoldHighView Rating Details
2/25/2019Chardan CapitalUpgradeNeutral ➝ Buy$35.00 ➝ $40.00HighView Rating Details
2/1/2019MizuhoReiterated RatingBuy$45.00HighView Rating Details
1/31/2019CowenReiterated RatingBuyMediumView Rating Details
1/11/2019GuggenheimUpgradeNeutral ➝ Buy$35.00HighView Rating Details
12/10/2018CitigroupLower Price TargetNeutral ➝ Neutral$40.00 ➝ $28.00LowView Rating Details
12/2/2018JPMorgan Chase & Co.Initiated CoverageOverweight$23.91HighView Rating Details
11/7/2018Raymond JamesReiterated RatingHoldHighView Rating Details
11/7/2018B. RileyBoost Price TargetSell$20.00 ➝ $21.00HighView Rating Details
10/8/2018WedbushLower Price TargetOutperform ➝ Outperform$52.00 ➝ $49.00LowView Rating Details
1/5/2018BMO Capital MarketsSet Price TargetBuy$44.00HighView Rating Details
11/15/2017Leerink SwannReiterated RatingOutperform$22.00 ➝ $29.00N/AView Rating Details
9/22/2017Bank of AmericaReiterated RatingBuy$23.00 ➝ $33.00LowView Rating Details
8/16/2017Evercore ISIInitiated CoverageOutperform ➝ Outperform$23.00LowView Rating Details
(Data available from 3/20/2017 forward)
This page was last updated on 3/20/2019 by Staff

Featured Article: What is a short straddle?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel